New Findings from the CONFIRM2 Registry Reveal Significant Gender Disparities in Coronary Plaque Features and Associated Risks for Major Adverse...
Cleerly to Present Late-Breaking Findings and Participate in Key ACC.25 Sessions
Cleerly will demonstrate its FDA-cleared heart image analyses using mobile scanners in collaboration with Corazon Imaging and Philips
Collaboration Expands Access to AI Technologies for Early Detection and Personalized Treatment of Coronary Artery Disease
